Researchers investigated whether low-dose hormone replacement therapy could benefit postmenopausal women experiencing chest discomfort and heart problems without blocked arteries. The study tested a combination of 1mg norethindrone and 10mcg ethinyl estradiol against placebo in 37 women. Scientists measured multiple cardiovascular markers including blood vessel function, lipid levels, glucose metabolism, and exercise stress responses. This comprehensive analysis aimed to determine if minimal hormone doses could provide heart protection while avoiding risks associated with higher-dose treatments that dominated earlier hormone therapy research.
